SCHEMBL18776492

SCHEMBL18776492

Cc1nc(N)nn2c([C@@H]3O[C@](C)(CO)[C@@H](O)[C@H]3F)cnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15257357 0.90 — —
SCHEMBL18193387 0.88 — —
SCHEMBL15257367 0.88 — —
SCHEMBL18776490 0.85 — —
SCHEMBL18193388 0.85 — —
SCHEMBL15257376 0.85 — —
SCHEMBL18193386 0.85 — —
SCHEMBL18193389 0.85 — —
SCHEMBL18776493 0.84 — —
SCHEMBL18776494 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170114086-A1 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. 2017-04-27 — — US disclosed
Send feedback